ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,780Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 783

$819K Total Retail Price of All Prescriptions

Rank: 89 out of 783

450 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 450 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

29% of this provider’s 450 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 10,908 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 703 421 S3 1 2
FUROSEMIDE 549 477 2 7
LEVOTHYROXINE SODIUM 525 425 3 1
WARFARIN SODIUM 379 343 4 10
AMLODIPINE BESYLATE 325 301 5 5
SIMVASTATIN 319 283 6 3
LISINOPRIL 314 242 7 4
OMEPRAZOLE 282 237 8 6
DONEPEZIL HCL 277 277 9 24
POTASSIUM CHLORIDE 276 225 10 16
NAMENDA 237 234 11 32
METOPROLOL TARTRATE 215 178 12 9
CYMBALTA 187 129 13 35
TRAMADOL HCL 181 166 14 20
METOPROLOL SUCCINATE 155 140 15 13
METFORMIN HCL 145 89 16 8
GABAPENTIN 141 110 17 15
CITALOPRAM HBR 138 113 18 19
LEVOFLOXACIN 132 107 19 75
FAMOTIDINE 132 126 19 55
CLOPIDOGREL 131 111 21 29
GLIMEPIRIDE 127 93 22 34
CIPROFLOXACIN HCL 123 103 23 62
PANTOPRAZOLE SODIUM 122 110 24 30
ZOLPIDEM TARTRATE 119 91 25 23
ESCITALOPRAM OXALATE 117 90 26 54
ISOSORBIDE MONONITRATE ER 115 92 27 40
SERTRALINE HCL 114 97 28 22
PRAVASTATIN SODIUM 114 85 28 14
CARVEDILOL 106 86 30 21
ROPINIROLE HCL 103 82 31 74
FENTANYL 102 77 S2 32 65
LANTUS 102 62 32 38
QUETIAPINE FUMARATE 93 87 34 79
PREDNISONE 91 80 35 36
TIZANIDINE HCL 87 45 36 133
NEXIUM 87 46 36 28
POLYETHYLENE GLYCOL 3350 86 75 38 43
MELOXICAM 85 80 39 37
TRAZODONE HCL 76 28 40 39
HUMALOG 73 58 41 101
CEPHALEXIN 73 58 41 70
CRESTOR 73 44 41 27
LEVETIRACETAM 71 62 44 89
DIGOXIN 71 71 44 61
DIVALPROEX SODIUM 69 60 46 72
METHYLPREDNISOLONE 66 52 47 138
SPIRIVA 65 56 48 59
BYSTOLIC 65 56 48 99
OXYCODONE HCL 64 28 S2 50 123
CLONIDINE HCL 63 62 51 60
MORPHINE SULFATE ER 62 55 S2 52 107
ONDANSETRON HCL 58 50 53 261
HYDRALAZINE HCL 58 41 53 78
VESICARE 56 47 55 188
ALLOPURINOL 54 33 56 31
PLAVIX 53 43 57 51
ATORVASTATIN CALCIUM 53 26 57 11
JANUMET 52 38 59 217
EXELON 52 52 59 109
ALBUTEROL SULFATE 51 47 61 136
MIRTAZAPINE 50 38 62 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.